Cellleris

Cellleris appears to be a small Swiss healthcare or biotechnology company associated with adipose-derived stem cell therapy and regenerative medicine. Publicly accessible evidence is sparse, but multiple market-research reports list Cellleris or Cellleris SA among companies active in adipose tissue-derived stem cell therapy, and Swiss business-registry aggregators indicate that CELERIS SA in Sion, Switzerland is an active company founded in 2018. Based on the limited available information, the company seems to be involved in stem cell storage, isolation, or therapeutic services related to adipose-derived stem cells rather than having a well-documented late-stage drug pipeline. Because primary company materials were not readily identifiable, several fields below are left null or empty rather than inferred beyond the available evidence.